33620 Results

People

  1. Ladanyi
    Ladanyi
  2. Giralt
    Giralt
  3. Motzer
    Motzer
  4. Reuter
    Reuter
  5. Perales
    Perales
  6. Scher
    Scher
  7. Zelenetz
    Zelenetz
  8. Berger
    Berger
  9. Al-Ahmadie
    Al-Ahmadie
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)
  7. Department of Pathology and Laboratory Medicine (5172)
  8. Surgery (4871)
  9. Sloan Kettering Institute Faculty (3826)
  10. Sloan Kettering Institute Postdocs (3612)
  1. "Meeting abstract"
Formats
  1. Meeting Abstract (33620)
Groups
  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)

More Groups

People
  1. Marc Ladanyi (641)
  2. Sergio Giralt (632)
  3. Robert Motzer (574)
  4. Victor Reuter (568)
  5. Miguel-Angel Perales (482)
  6. Howard Scher (463)

More People

Years
  1. 2025 (295)
  2. 2024 (1694)
  3. 2023 (1954)
  4. 2022 (2196)
  5. 2021 (1731)
  6. 2020 (1901)

More Years

Publications
  1. Journal of Clinical Oncology (6252)
  2. Blood (3939)
  3. Laboratory Investigation (1846)
  4. Cancer Research (1822)
  5. International Journal of Radiation Oncology, Biology, Physics (1643)
  6. Modern Pathology (1494)

More Publications

Publishers
  1. American Society of Clinical Oncology (6251)
  2. Elsevier Inc. (4694)
  3. American Society of Hematology (3939)
  4. American Association for Cancer Research (3045)
  5. Nature Publishing Group (2151)
  6. Oxford University Press (2096)

More Publishers

Results (33620)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Emerging real-world midostaurin treatment patterns and outcomes in FLT3-mutated acute myeloid leukemia at a comprehensive cancer center
    Meeting Abstract

    Willis, C.; Menon, J.; Unni, S.; Au, T.; Ndife, B.; Joseph, G. J.; Bonifacio, G. J.; Stein, E. M.; Tantravahi, S. K.; Shami, P. J.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Outcomes of pediatric patients with acute leukemia following adult unrelated donor transplant: The impact of donor KIR gene content and KIR ligand matching
    Meeting Abstract

    Verneris, M. R.; Wang, T.; Spellman, S. R.; Sees, J. A.; Haagenson, M. D.; Cooley, S.; Hsu, K. C.; Fleischhauer, K.; Fleischhauer, K.; Lee, D. A.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Measurement of serum microRNAs in US veterans with monoclonal gammopathy of undetermined significance
    Meeting Abstract

    Wang, W.; Shim, Y. K.; Michalek, J. E.; Barber, E.; Saleh, L. M.; Choi, B. Y.; Wang, C. P.; Ketchum, N.; Costello, R.; Marti, G. E.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • In vitro activity and target modulation of PV-10 against relapsed and refractory pediatric leukemia
    Meeting Abstract

    Swift, L.; Zhang, C. F.; Shah, R.; Trippett, T.; Narendran, A.
    Blood (2018)

    Fulltext@MSK | Save
  • Role of single agent and combination chemotherapy strategies in relapsed/refractory peripheral T-cell lymphoma: Results from the complete registry
    Meeting Abstract

    Stuver, R.; Khan, N.; Schwartz, M.; Acosta, M.; Federico, M.; Gisselbrecht, C.; Lansigan, F.; Pinter-Brown, L. C.; Pro, B.; Shustov, A. R.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Risk model for overall survival for patients with relapsed/refractory chronic lymphocytic leukemia: Validated for patients on ibrutinib, idelalisib, venetoclax, or chemoimmuniotheraphy
    Meeting Abstract

    Soumerai, J. D.; Ni, A.; Darif, M.; Londhe, A.; Xing, G.; Mun, Y.; Kay, N. E.; Shanafelt, T. D.; Chaffee, K. G.; Furman, R. R.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • mTOR-independent translation in early hematopoietic development
    Meeting Abstract

    Spevak, C.; Elias, H.; Kannan, L.; Martin, G.; Selvaraj, S.; Eng, W.; Ernlund, A.; Rajasekhar, V.; Woolthuis, C.; Schneider, R.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • The significance of leukocytosis in malignancies: A novel paradigm between leukocytosis, G-CSF, myeloid-derived suppressor cells and prognosis
    Meeting Abstract

    Tavakkoli, M.; Wilkins, C.; Mones, J. V.; Mauro, M. J.
    Blood (2018)

    Fulltext@MSK | Save
  • Continuous mobile wearable bio-monitoring of newly diagnosed multiple myeloma patients undergoing initial chemotherapy
    Meeting Abstract

    Tavitian, E.; Mastey, D.; Salcedo, M.; Zarski, A.; Chansakul, A.; Diab, V.; Mailankody, S.; Hassoun, H.; Lesokhin, A. M.; Lendvai, N.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Updated 18-month results from DASFREE: A study evaluating dasatinib discontinuation in patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP) and deep molecular response (DMR)
    Meeting Abstract

    Shah, N. P.; Gutiérrez, J. V. G.; Jiménez-Velasco, A.; Larson, S.; Saussele, S.; Rea, D.; Mahon, F. X.; Levy, M. Y.; Gómez-Casares, M. T.; Pane, F.; more...
    Blood (2018)

    Fulltext@MSK | Save